LegoChem Biosciences Financials
| 141080 Stock | KRW 95,500 3,900 3.92% |
LegoChem |
Understanding current and past LegoChem Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of LegoChem Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in LegoChem Biosciences' assets may result in an increase in income on the income statement.
Please note, the presentation of LegoChem Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LegoChem Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of LegoChem Biosciences' management manipulating its earnings.
LegoChem Biosciences Stock Summary
LegoChem Biosciences competes with Seoam Machinery, KEPCO Engineering, Dongil Technology, Tuksu Engineering, and Konan Technology. LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and ADC platform. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea. LegoChem Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7141080002 |
| Business Address | 8-26 Munpyeongseo-ro, Daejeon, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.legochembio.com |
| Phone | 82 4 2861 0688 |
| Currency | KRW - South Korean Won |
You should never invest in LegoChem Biosciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of LegoChem Stock, because this is throwing your money away. Analyzing the key information contained in LegoChem Biosciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
LegoChem Biosciences Key Financial Ratios
LegoChem Biosciences' financial ratios allow both analysts and investors to convert raw data from LegoChem Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of LegoChem Biosciences over time and compare it to other companies across industries.| Return On Equity | -2.16 | |||
| Return On Asset | 0.04 | |||
| Target Price | 50000.0 | |||
| Number Of Employees | 12 | |||
| Beta | 0.9 |
LegoChem Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LegoChem Biosciences's current stock value. Our valuation model uses many indicators to compare LegoChem Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LegoChem Biosciences competition to find correlations between indicators driving LegoChem Biosciences's intrinsic value. More Info.LegoChem Biosciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value LegoChem Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LegoChem Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.LegoChem Biosciences Systematic Risk
LegoChem Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. LegoChem Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on LegoChem Biosciences correlated with the market. If Beta is less than 0 LegoChem Biosciences generally moves in the opposite direction as compared to the market. If LegoChem Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one LegoChem Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of LegoChem Biosciences is generally in the same direction as the market. If Beta > 1 LegoChem Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
LegoChem Biosciences December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of LegoChem Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of LegoChem Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of LegoChem Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing LegoChem Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build LegoChem Biosciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.83 | |||
| Information Ratio | 0.0124 | |||
| Maximum Drawdown | 18.59 | |||
| Value At Risk | (5.67) | |||
| Potential Upside | 8.63 |
Complementary Tools for LegoChem Stock analysis
When running LegoChem Biosciences' price analysis, check to measure LegoChem Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LegoChem Biosciences is operating at the current time. Most of LegoChem Biosciences' value examination focuses on studying past and present price action to predict the probability of LegoChem Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LegoChem Biosciences' price. Additionally, you may evaluate how the addition of LegoChem Biosciences to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets |